Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
Yichao Hou, Xingqi Li, Chang Liu, et al.
Experimental Gerontology (2021) Vol. 150, pp. 111376-111376
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Manlian Zhu, Xia Liu, Yiru Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 102
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Redox Biology (2024) Vol. 71, pp. 103092-103092
Open Access | Times Cited: 27
Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model
Sonali Valvaikar, Bhupesh Vaidya, Shikha Sharma, et al.
Neurochemistry International (2024) Vol. 174, pp. 105691-105691
Closed Access | Times Cited: 16
Neurodegenerative disorders and gut-brain interactions
Alpana Singh, Ted M. Dawson, Subhash Kulkarni
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 83
A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice
Reem Abdel-Haq, Johannes C. M. Schlachetzki, Joseph C. Boktor, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 43
Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
Wenhui Lei, Yiwen Cheng, Jie Gao, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 40
Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease
Tongtong Guo, Zheng Zhang, Yan Sun, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 930-930
Open Access | Times Cited: 39
Microbiota from healthy mice alleviates cognitive decline via reshaping the gut-brain metabolic axis in diabetic mice
Qihui Zhao, Junli Chen, Mengjun Wu, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110638-110638
Closed Access | Times Cited: 36
Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
Yi Zhang, Shaoqing Xu, Yiwei Qian, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
Causal relationship between gut microflora and dementia: a Mendelian randomization study
Jinjie Fu, Yuan Qin, Ling‐Yong Xiao, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions
Ziwei Lan, Xiangqi Tang, Ming Lu, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26377-e26377
Open Access | Times Cited: 8
The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis
Mohamed J. Saadh, Shahad Mohammed Dhiaa, Pooja Bansal, et al.
Current Behavioral Neuroscience Reports (2025) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders
Sarika Yadav, Ashish Dwivedi, Anurag Tripathi, et al.
Nutrition Research (2022) Vol. 106, pp. 72-84
Closed Access | Times Cited: 34
Convergent pathways of the gut microbiota–brain axis and neurodegenerative disorders
Carolina Gubert, Juciano Gasparotto, Lívia H. Morais
Gastroenterology report (2022) Vol. 10
Open Access | Times Cited: 28
Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic
Wen-Xiang Duan, Fen Wang, Junyi Liu, et al.
Neuroscience Bulletin (2023) Vol. 40, Iss. 4, pp. 500-516
Open Access | Times Cited: 21
Nobiletin improves diphenoxylate-induced constipation and the accompanied depressive behavior disorders by regulating gut-SCFAs-brain axis
Xiangrui Kong, Jia Zhao, Huajing Gao, et al.
Food Bioscience (2024) Vol. 58, pp. 103808-103808
Closed Access | Times Cited: 6
Novel Pharmacotherapies in Parkinson’s Disease
Yousef Tizabi, Bruk Getachew, Michael Aschner
Neurotoxicity Research (2021) Vol. 39, Iss. 4, pp. 1381-1390
Open Access | Times Cited: 34
Bile acid receptors and signaling crosstalk in the liver, gut and brain
Jessica M. Ferrell, John Y.L. Chiang
Liver Research (2021) Vol. 5, Iss. 3, pp. 105-118
Open Access | Times Cited: 34
Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson’s disease
Martina Mazzocchi, Susan R. Goulding, Noelia Morales‐Prieto, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 151-160
Open Access | Times Cited: 25
Orally Induced High Serum Level of Trimethylamine N-oxide Worsened Glial Reaction and Neuroinflammation on MPTP-Induced Acute Parkinson’s Disease Model Mice
Chen-Meng Qiao, Wei Quan, Yu Zhou, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 9, pp. 5137-5154
Closed Access | Times Cited: 14
Neuroprotective Effect of a Multistrain Probiotic Mixture in SOD1G93A Mice by Reducing SOD1 Aggregation and Targeting the Microbiota-Gut-Brain Axis
Zikai Xin, Cheng Xin, Jia Huo, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10051-10071
Open Access | Times Cited: 4
The class-IIa HDAC inhibitor TMP269 promotes BMP-Smad signalling and is neuroprotective in in vitro and in vivo 6-hydroxydopamine models of Parkinson’s disease.
Alexander T. O’Mahony, Martina Mazzocchi, Alex Morris, et al.
Neuropharmacology (2025), pp. 110319-110319
Open Access
Sodium Butyrate ameliorates pain and mood disorders in a mouse model of Parkinson disease
Carmen Avagliano, Carmen De, Mariarosaria Cuozzo, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117903-117903
Closed Access
Page 1 - Next Page

Scroll to top